Sunday, 20 September 2026European Markets

GROUPE CRIT And SYNERGIE Have A High Dividend Yield And Return On Equity In The Staffing & Employment Services Industry.

Loading stream...

(vianews) - groupe crit (cen.pa) is among this list of stock assets with the highest dividend rate and return on equity on the staffing & employment services industry.

financial asset price forward dividend yield return on equity
groupe crit (cen.pa) €73.20 4.9% 10.2%
synergie (sdg.pa) €31.75 2.51% 15.16%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. groupe crit (cen.pa)

4.9% forward dividend yield and 10.2% return on equity

groupe crit sa provides temporary work and recruitment services in france and internationally. the company offers temporary work and recruitment, and training and consulting services. it also provides airport assistance, such as ground solutions, congo handling, and technical assistance services, as well as offers engineering and maintenance services. groupe crit sa was founded in 1962 and is headquartered in paris, france.

earnings per share

as for profitability, groupe crit has a trailing twelve months eps of €6.12.

pe ratio

groupe crit has a trailing twelve months price to earnings ratio of 11.96. meaning, the purchaser of the share is investing €11.96 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.2%.

more news about groupe crit.

2. synergie (sdg.pa)

2.51% forward dividend yield and 15.16% return on equity

synergie se provides human resources management and development services for companies and institutions in france, belgium, other northern and eastern europe, italy, spain, portugal, canada, and australia. it offers temporary work, recruitment, out-placement, social engineering, consultancy, and training services. the company serves various specialized sectors and industries, such as renewable energy, transport and logistics, construction and public works, healthcare, agri-food, and tertiary sectors. synergie se was founded in 1969 and is headquartered in paris, france.

earnings per share

as for profitability, synergie has a trailing twelve months eps of €3.51.

pe ratio

synergie has a trailing twelve months price to earnings ratio of 9.05. meaning, the purchaser of the share is investing €9.05 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 15.16%.

moving average

synergie's worth is under its 50-day moving average of €32.61 and under its 200-day moving average of €32.51.

volume

today's last reported volume for synergie is 350 which is 86.36% below its average volume of 2567.

revenue growth

year-on-year quarterly revenue growth grew by 4.9%, now sitting on 2.92b for the twelve trailing months.

more news about synergie.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Boom Hits a Fork: Slowdown Calls Clash with Capex Confidence as Markets Get Nervous
Dario Amodei's repeated calls for a global slowdown in frontier AI development, echoed by Microsoft's new humanist AI code of conduct and FTC antitrust caution, are being publicly rejected by Nvidia and Meta leadership even as hyperscaler spending draws fresh skeptical scrutiny (Wachter's analysis, Burry-style overbuilding worries) and weak guidance from Adobe and a post-slowdown-comment selloff in GE Vernova signal investor jitters. Meanwhile wealth and security effects of the AI race keep compounding — Zhang Yiming's fortune surging on AI-driven ByteDance value, a Chinese hacking firm weaponizing AI against stolen government secrets, and low-quality AI-generated products (an AI sitcom, a spam-flooding agent platform) fueling backlash even as adoption races ahead.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,982
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,982 facts checked against source5,299 source documents archived
Query this data → isubstrate.com